Hamada, Eriko
Sakai, Kazuya
Yamada, Shinya
Kubo, Masayuki
Hayakawa, Masaki
Matsumoto, Masanori https://orcid.org/0000-0002-7243-3126
Funding for this research was provided by:
Ministry of Health, Labour and Welfare
Article History
Received: 13 January 2022
Accepted: 26 January 2022
First Online: 4 February 2022
Declarations
:
: This study was approved by the ethics committee of Nara Medical University and was compliant with the Declaration of Helsinki. Informed consent was obtained from all patients included in this study.
: M. Matsumoto is a member of the clinical advisory bord of Takeda Yakuhin. He is also an inventor of ADAMTS13 act-ELISA. The remaining authors declare no competing financial interests.
Free to read: This content has been made available to all.